Author

Emmett Tse

OpenAlex ID: A5085847217

Silmitasertib plus gemcitabine and cisplatin first‐line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study

2022 · Mitesh J. Borad, Li‐Yuan Bai, et al. · Hepatology · 32

Silmitasertib (CX-4945) in combination with gemcitabine and cisplatin as first-line treatment for patients with locally advanced or metastatic cholangiocarcinoma: A phase Ib/II study.

2021 · Mitesh J. Borad, Li-Yuan Bai, et al. · Journal of Clinical Oncology · 25

Works count: 2

Citation count: 57

H-index: 2

I10-index: 2